PTK2 and colorectal carcinoma: The inhibition of FAK by a genetic or a pharmacologic method decreased the EMT features and aggressiveness in colorectal carcinoma cell lines [175,176] and triple negative breast cancer cell lines in vitro [177], but not in NSCLC cell lines in vitro [178].